Inhalation Sciences Sweden AB Stock OTC Markets
Stocks
INHSF
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 08-24 | Inhalation Sciences Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-24 | Inhalation Sciences narrows its loss | FW |
| Market Cap | 7.17M 757K 649K 608K 555K 1.05M 72.15M 1.06M 2.79M 36.4M 2.84M 2.78M 121M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.34M 458K 392K 368K 336K 634K 43.65M 640K 1.69M 22.02M 1.72M 1.68M 72.94M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
81.56% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 2019-09-15 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 2004-12-31 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 2025-06-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 2004-12-31 |
Jan Hellqvist
BRD | Director/Board Member | - | 2022-08-31 |
Ulf Ericsson
BRD | Director/Board Member | - | 2024-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 757K | |
| -0.09% | +6.64% | +28.00% | +15.98% | 232B | |
| +0.40% | +8.21% | +3.97% | -15.48% | 152B | |
| -0.46% | -4.94% | -20.62% | +24.97% | 131B | |
| +1.73% | -1.21% | -52.56% | -1.77% | 72.26B | |
| -1.08% | -1.75% | -16.85% | -14.14% | 51.57B | |
| +0.41% | -0.12% | +12.38% | +19.30% | 52.38B | |
| +0.87% | +4.26% | +29.90% | +29.32% | 43.71B | |
| +0.90% | +3.29% | +38.63% | +51.60% | 40.72B | |
| +0.79% | +19.49% | +125.76% | +42.33% | 33.97B | |
| Average | +0.24% | +3.90% | +16.51% | +16.90% | 90.01B | |
| Weighted average by Cap. | +0.19% | +3.71% | +9.30% | +11.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.17M 999K 937K 855K 1.61M 111M 1.63M 4.3M 56.1M 4.38M 4.28M 186M | 3.04M 321K 275K 258K 235K 444K 30.61M 449K 1.18M 15.44M 1.21M 1.18M 51.14M |
| Net income | -5.15M -543K -466K -436K -399K -752K -51.81M -760K -2M -26.14M -2.04M -2M -86.56M | -10.16M -1.07M -919K -861K -787K -1.48M -102M -1.5M -3.96M -51.6M -4.03M -3.94M -171M |
| Net Debt | -4M -423K -362K -339K -310K -585K -40.29M -591K -1.56M -20.33M -1.59M -1.55M -67.32M | -2.83M -299K -256K -240K -219K -414K -28.5M -418K -1.1M -14.38M -1.12M -1.1M -47.61M |
Employees
5
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- INHSF Stock
Select your edition
All financial news and data tailored to specific country editions
